Bloomage Biotech

Forecast & Rating8 analysts currently cover Bloomage Biotech, with about 25.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥39.70, about 7.2% upside from the current price of ¥37.02. Price targets range from ¥25.00 to ¥60.00 — a wide spread, showing clear disagreement over just how much Bloomage Biotech can rise. Historically, about 36.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bloomage Biotech's outlook. Data as of Aug 18, 2026; for reference only and not investment advice.